419 related articles for article (PubMed ID: 19160192)
1. Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma.
Samuel M; Chow PK; Chan Shih-Yen E; Machin D; Soo KC
Cochrane Database Syst Rev; 2009 Jan; 2009(1):CD001199. PubMed ID: 19160192
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant and adjuvant therapy for operable hepatocellular carcinoma.
Chan ES; Chow PK; Tai B; Machin D; Soo K
Cochrane Database Syst Rev; 2000; (2):CD001199. PubMed ID: 10796754
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma.
Weis S; Franke A; Berg T; Mössner J; Fleig WE; Schoppmeyer K
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD006745. PubMed ID: 25620061
[TBL] [Abstract][Full Text] [Related]
4. Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma.
Abdel-Rahman O; Elsayed Z
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD011313. PubMed ID: 31978267
[TBL] [Abstract][Full Text] [Related]
5. Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma.
Abdel-Rahman OM; Elsayed Z
Cochrane Database Syst Rev; 2016 Feb; 2():CD011313. PubMed ID: 26905230
[TBL] [Abstract][Full Text] [Related]
6. External beam radiotherapy for unresectable hepatocellular carcinoma.
Abdel-Rahman O; Elsayed Z
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011314. PubMed ID: 28267205
[TBL] [Abstract][Full Text] [Related]
7. The combination of transcatheter arterial chemoembolisation (TACE) and thermal ablation versus TACE alone for hepatocellular carcinoma.
Liu B; Zhang Y; Chen H; Li W; Tsochatzis E
Cochrane Database Syst Rev; 2022 Jan; 1(1):CD013345. PubMed ID: 34981511
[TBL] [Abstract][Full Text] [Related]
8. Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma.
Oliveri RS; Wetterslev J; Gluud C
Cochrane Database Syst Rev; 2011 Mar; (3):CD004787. PubMed ID: 21412886
[TBL] [Abstract][Full Text] [Related]
9. Management of people with early- or very early-stage hepatocellular carcinoma: an attempted network meta-analysis.
Majumdar A; Roccarina D; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011650. PubMed ID: 28351116
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma.
Schoppmeyer K; Weis S; Mössner J; Fleig WE
Cochrane Database Syst Rev; 2009 Jul; (3):CD006745. PubMed ID: 19588401
[TBL] [Abstract][Full Text] [Related]
11. Transarterial (chemo)embolisation versus no intervention or placebo for liver metastases.
Swierz MJ; Storman D; Riemsma RP; Wolff R; Mitus JW; Pedziwiatr M; Kleijnen J; Bala MM
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009498. PubMed ID: 32163181
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials.
Schwartz JD; Schwartz M; Mandeli J; Sung M
Lancet Oncol; 2002 Oct; 3(10):593-603. PubMed ID: 12372721
[TBL] [Abstract][Full Text] [Related]
13. Transarterial (chemo)embolisation versus no intervention or placebo intervention for liver metastases.
Riemsma RP; Bala MM; Wolff R; Kleijnen J
Cochrane Database Syst Rev; 2013 Apr; (4):CD009498. PubMed ID: 23633373
[TBL] [Abstract][Full Text] [Related]
14. Radiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinoma.
Weis S; Franke A; Mössner J; Jakobsen JC; Schoppmeyer K
Cochrane Database Syst Rev; 2013 Dec; (12):CD003046. PubMed ID: 24357457
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant chemotherapy plus surgery versus surgery for cervical cancer.
Rydzewska L; Tierney J; Vale CL; Symonds PR
Cochrane Database Syst Rev; 2012 Dec; 12(12):CD007406. PubMed ID: 23235641
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial.
Bruix J; Takayama T; Mazzaferro V; Chau GY; Yang J; Kudo M; Cai J; Poon RT; Han KH; Tak WY; Lee HC; Song T; Roayaie S; Bolondi L; Lee KS; Makuuchi M; Souza F; Berre MA; Meinhardt G; Llovet JM;
Lancet Oncol; 2015 Oct; 16(13):1344-54. PubMed ID: 26361969
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant chemotherapy plus surgery versus surgery for cervical cancer.
Rydzewska L; Tierney J; Vale CL; Symonds PR
Cochrane Database Syst Rev; 2010 Jan; (1):CD007406. PubMed ID: 20091632
[TBL] [Abstract][Full Text] [Related]
18. Transarterial (chemo)embolisation versus no intervention or placebo intervention for liver metastases.
Riemsma RP; Bala MM; Wolff R; Kleijnen J
Cochrane Database Syst Rev; 2012 Sep; (9):CD009498. PubMed ID: 22972145
[TBL] [Abstract][Full Text] [Related]
19. Lamivudine with or without adefovir dipivoxil for postoperative hepatocellular carcinoma.
Zhong JH; Li le Q; Wu LC
Cochrane Database Syst Rev; 2011 Dec; (12):CD008713. PubMed ID: 22161435
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trial.
Marron TU; Fiel MI; Hamon P; Fiaschi N; Kim E; Ward SC; Zhao Z; Kim J; Kennedy P; Gunasekaran G; Tabrizian P; Doroshow D; Legg M; Hammad A; Magen A; Kamphorst AO; Shareef M; Gupta NT; Deering R; Wang W; Wang F; Thanigaimani P; Mani J; Troncoso L; Tabachnikova A; Chang C; Akturk G; Buckup M; Hamel S; Ioannou G; Hennequin C; Jamal H; Brown H; Bonaccorso A; Labow D; Sarpel U; Rosenbloom T; Sung MW; Kou B; Li S; Jankovic V; James N; Hamon SC; Cheung HK; Sims JS; Miller E; Bhardwaj N; Thurston G; Lowy I; Gnjatic S; Taouli B; Schwartz ME; Merad M
Lancet Gastroenterol Hepatol; 2022 Mar; 7(3):219-229. PubMed ID: 35065058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]